(Q34390771)

1 August 2017

Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases (English)

1 reference

1 August 2017

Ryosuke Tateishi

1

0 references

author name string

Shuichiro Shiina

2

1 reference

1 August 2017

Takuma Teratani

3

1 reference

1 August 2017

Shuntaro Obi

4

1 reference

1 August 2017

Shinpei Sato

5

1 reference

1 August 2017

Yukihiro Koike

6

1 reference

1 August 2017

Tomonori Fujishima

7

1 reference

1 August 2017

Haruhiko Yoshida

8

1 reference

1 August 2017

Takao Kawabe

9

1 reference

1 August 2017

Masao Omata

10

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

1 August 2017

1 reference

1 August 2017

103

1 reference

1 August 2017

6

1 reference

1 August 2017

1201-1209

1 reference

NIH conference. Hepatocellular carcinoma

1 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Surgery for small liver cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Power Doppler signals after percutaneous ethanol injection therapy for hepatocellular carcinoma predict local recurrence of tumors: a prospective study using 199 consecutive patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

A cooled needle electrode for radiofrequency tissue ablation: thermodynamic aspects of improved performance compared with conventional needle design

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Adverse events during radiofrequency treatment of 582 hepatic tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Image-guided tumor ablation: proposal for standardization of terms and reporting criteria

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Percutaneous radiofrequency tissue ablation: optimization of pulsed-radiofrequency technique to increase coagulation necrosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Complications of radiofrequency coagulation of liver tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Predictive factors for postoperative recurrence of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20892

7 January 2021

Identifiers

DOI

10.1002/CNCR.20892

1 reference

1 August 2017

1 reference